{"id":11261,"date":"2025-11-06T07:45:00","date_gmt":"2025-11-06T07:45:00","guid":{"rendered":"https:\/\/acarix.com\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/"},"modified":"2025-11-06T07:45:00","modified_gmt":"2025-11-06T07:45:00","slug":"invitation-to-presentation-of-acarixs-third-quarter-2025-report","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/","title":{"rendered":"Invitation to presentation of Acarix\u00b4s third quarter 2025 report"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p class=\"mfn-wp-retain\"><strong>Acarix third quarter result is now released and we invite investors, analysts, and media representatives to join the recorded webcast presentation of the third quarter report for 2025. The presentation is led by CEO Aamir Mahmood and is conducted in English.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p class=\"mfn-wp-retain\">The report is found here : <a href=\"https:\/\/acarix.com\/investor-presentations\/\" rel=\"noopener\" target=\"_blank\">https:\/\/acarix.com\/investor-presentations\/<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-ddf9d1ef3849\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">About Acarix<\/strong><\/p>\n<table style=\"border-collapse: collapse;margin-bottom: 1em;margin-top: 1em\">\n<tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" valign=\"middle\">Acarix is a Swedish medical device company that innovates solutions for rapid rule out of coronary artery disease (CAD) at point of care. The CE-approved and FDA DeNovo-cleared Acarix CADScor System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive, and costly diagnostic procedures. The CADScor System has been used on more than 40,000 patients. Acarix recommends CADScor System as a first-line diagnostic aid that uses highly sensitive acoustics and advanced computational processing to analyze coronary blood flow to rule out significant coronary artery disease (CAD), with at least 96% certainty at point of care. Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX) and cross-traded on the OTCQB market in the US (ticker: ACIXF). The Company&rsquo;s Certified Adviser is Tapper Partners AB. For more information, please visit <a href=\"http:\/\/www.acarix.com\" rel=\"noopener\" target=\"_blank\">www.acarix.com<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"mfn-footer mfn-bb68ac3e1d46\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">For more information, contact<\/strong><br \/>Macie May, phone +1 405 517 5161, email <a href=\"mailto:awilson@saxum.com\" rel=\"noopener\" target=\"_blank\">mmay@saxum.com<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">Attachments<\/strong><br \/><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/3c3b9fa5-7e91-4431-8deb-9f828d40594c\/invitation-to-presentation-of-acarix-s-third-quarter-2025-report.pdf\" rel=\"noopener\" target=\"_blank\">Invitation to presentation of Acarix&acute;s third quarter 2025 report<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment mfn-primary\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/3c3b9fa5-7e91-4431-8deb-9f828d40594c\/invitation-to-presentation-of-acarix-s-third-quarter-2025-report.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/3c3b9fa5-7e91-4431-8deb-9f828d40594c\/invitation-to-presentation-of-acarix-s-third-quarter-2025-report.pdf?type=jpg\"><\/span>Invitation to presentation of Acarix\u00b4s third quarter 2025 report<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Acarix third quarter result is now released and we invite investors, analysts, and media representatives to join the recorded webcast<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[177,143,140,139,181],"tags":[],"class_list":["post-11261","post","type-post","status-publish","format-standard","hentry","category-mfn-ci","category-mfn-lang-en","category-mfn-type-ir","category-mfn","category-mfn-ci-other"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Invitation to presentation of Acarix\u00b4s third quarter 2025 report - Acarix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invitation to presentation of Acarix\u00b4s third quarter 2025 report - Acarix\" \/>\n<meta property=\"og:description\" content=\"Acarix third quarter result is now released and we invite investors, analysts, and media representatives to join the recorded webcast\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T07:45:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Invitation to presentation of Acarix\u00b4s third quarter 2025 report\",\"datePublished\":\"2025-11-06T07:45:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\\\/\"},\"wordCount\":229,\"articleSection\":[\"Corporate Information\",\"English\",\"IR\",\"News\",\"Other Corporate Information\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\\\/\",\"name\":\"Invitation to presentation of Acarix\u00b4s third quarter 2025 report - Acarix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"datePublished\":\"2025-11-06T07:45:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invitation to presentation of Acarix\u00b4s third quarter 2025 report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Invitation to presentation of Acarix\u00b4s third quarter 2025 report - Acarix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Invitation to presentation of Acarix\u00b4s third quarter 2025 report - Acarix","og_description":"Acarix third quarter result is now released and we invite investors, analysts, and media representatives to join the recorded webcast","og_url":"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/","og_site_name":"Acarix","article_published_time":"2025-11-06T07:45:00+00:00","og_image":[{"width":1200,"height":673,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/#article","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/"},"author":{"name":"","@id":""},"headline":"Invitation to presentation of Acarix\u00b4s third quarter 2025 report","datePublished":"2025-11-06T07:45:00+00:00","mainEntityOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/"},"wordCount":229,"articleSection":["Corporate Information","English","IR","News","Other Corporate Information"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/","url":"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/","name":"Invitation to presentation of Acarix\u00b4s third quarter 2025 report - Acarix","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"datePublished":"2025-11-06T07:45:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"Invitation to presentation of Acarix\u00b4s third quarter 2025 report"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/11261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=11261"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/11261\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=11261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/categories?post=11261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/tags?post=11261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}